Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The 2023 General State Budget in the field of health announced in Spain

On October 19, 2022, it was announced by the Ministry of Health that the 2023 General State Budget in the field of health would comprise €2,746.17 million, which is €199.32 million (7.83%) more than in 2022. The total amount to be allocated to the Ministry of Health and its attached public bodies (the Spanish Agency for Medicines and Health Products, the National Transplant Organization, and the National Institute of Health Management) includes both the national budget and the one destined to the execution of projects financed with the European funds. The aim is to strengthen the National Health System (SNS) and achieve a more robust, more equitable, and more modern system capable of adapting to the population's health needs.

The key investments include:

  • The allocation of €172.4 million in transfers to Autonomous Communities and Cities for the Primary Care Action Plan 2022-2023, to which is added another €434 million for the improvement of infrastructures and equipment. This endowment will allow facing projects of new construction, reform, or expansion of health centers and offices, as well as conventional radiology, dentistry, or physiotherapy rooms in Primary Care;
  • In order to increase the capacity to respond to future health crises €3.2 million will be allocated for the technological equipment of the State Public Health Agency and €4.2 million for the Public Health surveillance network;
  • €40 million to strengthen mental health care at all levels;
  • €6 million for population screenings in areas such as colon and cervical cancer;
  • €2.8 million for the Strategy against rare and neurodegenerative diseases (including amyotrophic lateral sclerosis);
  • €2 million for programs to prevent and control acquired immune deficiency syndrome and other sexually transmitted infections;
  • €70 million for the care of patients with rare diseases, including the implementation of the new neonatal screening programs included in the Common Package of Benefits of the SNS, implementation of the latest updates of the orthoprosthetic service catalog, including the eye reader or other communication systems for patients with severe neuromotor disorders, and the improvement of infrastructures and acquisition of equipment for the service centers and reference units of the SNS;
  • €100 million for the Genomics Portfolio Implementation Plan;
  • €24.3 million to continue the development of the Proton Therapy Implementation Plan;
  • €44 million for the expansion of the Common Package of oral health services of the SNS;
  • €285 million for the National Digital Health Strategy, including €160 million for the implementation in the health centers of the SNS of new technologies that increase the quality and equity in the attention to citizens, €100 million for the construction of the National Health Data Space.

The full details in Spanish can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.